🇺🇸 FDA

Intelligence Platform

Patents

Browse 215 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11814625

Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease

Carleton University · Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11759453

SHMT inhibitors

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11739345

Methods of treating phenylketonuria

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11737981

Cellulosic polymer nanoparticles and methods of forming them

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11731099

Method for controlling encapsulation efficiency and burst release of water soluble molecul

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11684612

Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid rece

Corcept Therapeutics Incorporated · Granted Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11648245

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11634540

Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

Nektar Therapeutics · Granted Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11629174

Cryptic metabolites and method for activating silent biosynthetic gene clusters in actinom

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11590113

Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid rece

Corcept Therapeutics Incorporated · Granted Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11576907

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11554101

Process for encapsulating soluble biologics, therapeutics, and imaging agents

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11549950

Cryptic metabolites and method for activating silent biosynthetic gene clusters in diverse

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11498970

Human antibodies to the human glucagon receptor and methods of use thereof to lower blood

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11486802

Methods and devices for high throughput purification

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11464764

Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin

Corcept Therapeutics Incorporated · Granted Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11376225

Composite flash-precipitated nanoparticles

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11369588

NADPH production by the 10-formyl-THF pathway, and its use in the diagnosis and treatment

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11312756

Engineered potent cytotoxic stapled BH3 peptides

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11306288

Methods for preparing therapeutically active cells using microfluidics

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11266611

More potent and less toxic formulations of epinephrine and methods of medical use

Eton Pharmaceuticals, Inc. · Granted Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11234953

Ketone bodies to protect tissues from damage by ionizing radiation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11236080

Protein kinase inhibitors

Princeton Drug Discovery, Inc · Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11220575

Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method

Nektar Therapeutics · Granted Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted